Compounds > brexanolone
Page last updated: 2024-08-26

brexanolone and Depressive Disorder, Treatment-Resistant

brexanolone has been researched along with Depressive Disorder, Treatment-Resistant in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Cristea, IA; Naudet, F1
Daly, EJ; Drevets, WC; Fedgchin, M; Hough, D; Mathews, M; Popova, V; Singh, JB1
Kleinman, RA; Schatzberg, AF1

Other Studies

3 other study(ies) available for brexanolone and Depressive Disorder, Treatment-Resistant

ArticleYear
US Food and Drug Administration approval of esketamine and brexanolone.
    The lancet. Psychiatry, 2019, Volume: 6, Issue:12

    Topics: Antidepressive Agents; beta-Cyclodextrins; Depression, Postpartum; Depressive Disorder, Treatment-Resistant; Drug Combinations; Female; Humans; Ketamine; Pregnanolone; United States; United States Food and Drug Administration

2019
Approval of esketamine for treatment-resistant depression.
    The lancet. Psychiatry, 2020, Volume: 7, Issue:3

    Topics: beta-Cyclodextrins; Depression; Depressive Disorder, Treatment-Resistant; Drug Combinations; Humans; Ketamine; Pregnanolone; United States; United States Food and Drug Administration

2020
Understanding the Clinical Effects and Mechanisms of Action of Neurosteroids.
    The American journal of psychiatry, 2021, 03-01, Volume: 178, Issue:3

    Topics: Antidepressive Agents; beta-Cyclodextrins; Depressive Disorder, Treatment-Resistant; Drug Combinations; Humans; Neurosteroids; Pregnanes; Pregnanolone; Pyrazoles

2021